Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2022 ∙ Rinaldi, V. Bellucci, G. Buscarinu, M. C. Reniè, R. Marrone, A. Nasello, M. Zancan, V. Nistri, R. Palumbo, R. Salerno, A. Salvetti, M. Ristori, G.

CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Janssen, C. Mosnier, A. Gavazzi, G. Combadière, B. Crépey, P. Gaillat, J. Launay, O. Botelho-Nevers, E.

Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies

  • Adults
  • Older adults
  • COVID-19
  • Influenza
  • Administration
  • Safety
  • Acceptance
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Tzenios, N. Tazanios, M. E. Chahine, M.

Combining Influenza and COVID-19 Booster Vaccination Strategy to Improve Vaccination Uptake Necessary for Managing the Health Pandemic: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Sutton, N. San Francisco Ramos, A. Beales, E. Smith, D. Ikram, S. Galiza, E. Hsia, Y. Heath, P. T.

Comparing Reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Deng, J. Ma, Y. Liu, Q. Du, M. Liu, M. Liu, J.

Comparison of the Effectiveness and Safety of Heterologous Booster Doses with Homologous Booster Doses for SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • Healthcare workers
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Alinaghi, S. A. S. MohsseniPour, M. Saeidi, S. Habibi, P. Dashti, M. Nazarian, N. Noori, T. Pashaei, Z. Bagheri, A. B. Ghasemzadeh, A. Afsahi, A. M. Aghaie, N. Mojdeganlou, P. Arjmand, G. Zargari, G. Modiri, R. Mojdeganlou, H. Razi, A. Mehraeen, E. Dadras, O.

Complications of COVID-19 Vaccines during Pregnancy; a Systematic Review

  • Pregnant women
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Huang, L. Y. Chiang, C. C. Li, Y. L. Lai, H. Y. Hsieh, Y. C. Wu, Y. H. Tsai, Y. Y.

Corneal Complications after COVID-19 Vaccination: A Systemic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Siahaan, Y. M. T. Hartoyo, V. Hariyanto, T. I. Kurniawan, A.

Coronavirus disease 2019 (Covid-19) outcomes in patients with sarcopenia: A meta-analysis and meta-regression

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Bronz, G. Faré, P. B. Lava, S. A. G. Bianchetti, M. G. Simonetti, G. D. Scoglio, M. Beretta-Piccoli, B. T. Agostoni, C. Milani, G. P.

Coronavirus disease 2019, vaccination against coronavirus and immunoglobulin A-mediated diseases: systematic literature review

  • Adolescents
  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Zhou, L. Yan, W. Li, S. Yang, H. Zhang, X. Lu, W. Liu, J. Wang, Y.

Cost-effectiveness of interventions for the prevention and control of COVID-19: Systematic review of 85 modelling studies

  • All age groups
  • COVID-19
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
Loading...